- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/381 - Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
Patent holdings for IPC class A61K 31/381
Total number of patents in this class: 3613
10-year publication summary
204
|
176
|
202
|
206
|
216
|
204
|
230
|
169
|
207
|
147
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2339 |
80 |
Antecip Bioventures II LLC | 339 |
57 |
Janssen Pharmaceutica N.V. | 3381 |
44 |
The Regents of the University of California | 20035 |
36 |
Novartis AG | 10726 |
28 |
Bristol-myers Squibb Company | 4867 |
26 |
Takeda Pharmaceutical Company Limited | 2707 |
25 |
Sunovion Pharmaceuticals Inc. | 263 |
25 |
Astellas Pharma Inc. | 1083 |
22 |
LTS Lohmann Therapie-Systeme AG | 707 |
21 |
Boehringer Ingelheim International GmbH | 4640 |
19 |
Dana-Farber Cancer Institute, Inc. | 2577 |
18 |
Gilead Sciences, Inc. | 2042 |
18 |
Centre National de La Recherche Scientifique | 10498 |
17 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2880 |
17 |
The General Hospital Corporation | 4759 |
16 |
Vertex Pharmaceuticals Incorporated | 1619 |
15 |
Mitsubishi Tanabe Pharma Corporation | 581 |
15 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3178 |
15 |
F. Hoffmann-La Roche AG | 7942 |
14 |
Other owners | 3085 |